Symbionix

Symbionix is engaged in the development of exoskeletons of various functional directions. The main direction of development is the creation of high-tech exoskeletons for the rehabilitation of people with disabilities. The company is a resident of Skolkovo.

History

2021: Bankruptcy lawsuit from ICC Demetra

At the end of September 2021, it became known about the second bankruptcy lawsuit, which ICC Demetra filed against Symbionix. The first application dates back to April 12, 2021, but a few months later the court proceedings were discontinued due to the refusal of the creditor to cover the costs of bankruptcy proceedings and the lack of evidence of the debtor's property.

According to Kommersant, citing Anton Fomin, senior lawyer of the bankruptcy department of Crowe CRS Legal, who, in turn, cites data from the My Arbiter system, from 2018 to September 2021. Decisions were made against Symbionix to recover 6.2 million rubles, of which the debt to Demeter ICC is 5.3 million rubles.

Creditors will bankrupt the developer of medical exoskeletons Symbionix from Skolkovo

According to the lawyer, in total, debts worth more than 11 million rubles are collected from the developer of medical exoskeletons in the amount of claims of Terminal and SME Corporation. The total amount of requirements for Symbionix is at least 17 million rubles.

Fomin says that the likelihood of bankruptcy directly depends on the actions of the company's management to pay off the debt of Demeter ICC or its restructuring.

Symbionix planned to launch the production of robotic devices in Tver designed to compensate for lost functions and increase the strength of human muscles. For these and other purposes, the startup took a loan of 100 million rubles from SME Bank. In addition, the company received an independent guarantee from SME Corporation for startups for 70 million rubles and financing in the form of a contribution to the authorized capital of 20 million rubles from the Mir fund. ^[1]

Notes